Adam Afshar
Director/Miembro de la Junta en Ariana Pharmaceuticals SA .
Perfil
Adam Afshar was the founder of Hyde Park Global Investments LLC, which he founded in 2005 and where he held the titles of President & Chief Executive Officer.
He is currently a Director at Ariana Pharmaceuticals SA. Mr. Afshar obtained an MBA from The University of Chicago.
Cargos activos de Adam Afshar
| Empresas | Cargo | Inicio |
|---|---|---|
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Director/Miembro de la Junta | 12/11/2009 |
Antiguos cargos conocidos de Adam Afshar.
| Empresas | Cargo | Fin |
|---|---|---|
Hyde Park Global Investments LLC
 Hyde Park Global Investments LLC Investment Banks/BrokersFinance Hyde Park Global Partners LLC offers a software-based investment and trading services. Its system is built primarily on genetic algorithms and other models to identify mispricing, arbitrage, and patterns in the electronic financial markets. The firm also develops robotic platform to monetize opportunities. The company was founded on May 26, 2005 and is headquartered in Atlanta, GA. | Director Ejecutivo | - |
Formación de Adam Afshar.
| The University of Chicago | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Health Technology |
Hyde Park Global Investments LLC
Hyde Park Global Investments LLC Investment Banks/BrokersFinance Hyde Park Global Partners LLC offers a software-based investment and trading services. Its system is built primarily on genetic algorithms and other models to identify mispricing, arbitrage, and patterns in the electronic financial markets. The firm also develops robotic platform to monetize opportunities. The company was founded on May 26, 2005 and is headquartered in Atlanta, GA. | Finance |
- Bolsa de valores
- Insiders
- Adam Afshar